Φορτώνει......
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors
Tumor targeting by genetically modified mesenchymal stromal/stem cells (MSCs) carrying anti-cancer molecules represents a promising cell-based strategy. We previously showed that the pro-apoptotic agent tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can be successfully delivered by...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Gene Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Nature Publishing Group US
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7445885/ https://ncbi.nlm.nih.gov/pubmed/30464207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41417-018-0062-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|